Morgan Stanley Analyst Says Tesla/Lemonade Partnership Will Drive Auto Insurance Innovation
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 9h ago
0mins
Morgan Stanley analyst Bob Huang says the Tesla (TSLA)/Lemonade (LMND) partnership underscores more opportunities in auto insurance, as higher repair costs, unclear liability, and disrupted risk segmentation should support premiums and product innovation over time. In the firm's view, Lemonade's AV insurance product validates autonomous driving progress. Morgan Stanley Tesla/Lemonade deal will chart a path for auto insurance future, not destroy it.
Analyst Views on LMND
Wall Street analysts forecast LMND stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LMND is 77.60 USD with a low forecast of 40.00 USD and a high forecast of 98.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
2 Buy
3 Hold
1 Sell
Hold
Current: 93.250
Low
40.00
Averages
77.60
High
98.00
Current: 93.250
Low
40.00
Averages
77.60
High
98.00
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.








